Risk of developing dementia in people with diabetes and mild cognitive impairment

British Journal of Psychiatry

Volumn 196, Issue 1, 2010, Pages 36-40

  Velayudhan, Latha ^a   Poppe, Michaela ^b   Archer, Nicola ^b   Proitsi, Petroula ^a   Brown, Richard G ^a,b   Lovestone, Simon ^a  

^a King s College London   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTITIONER; GENOTYPE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PRIMARY MEDICAL CARE; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEMENTIA; DIABETES COMPLICATIONS; DISEASE PROGRESSION; FEMALE; HUMANS; LONDON; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 74949127586     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.067942     Document Type: Article

References (30)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112-7.
2. Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr 2004; 16: 129-40.
3. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63: 658-63.
4. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007; 64: 570-5.
5. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64-74.
6. Biessels GJ, Deary U, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008; 7: 184-90.
7. Das SK, Bose P, Biswas A, Dutt A, Banerjee TK, Hazra AM, et al. An epidemiologic study of mild cognitive impairment in Kolkata, India. Neurology 2007; 68: 2019-26.
8. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
9. Ellul J, Archer N, Foy CM, Poppe M, Boothby H, Nicholas H, et al. The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration. J Neurol Neurosurg Psychiatry 2007; 78: 233-9.
10. Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, et al. Proteome-based plasma biomarkers for Alzheimer's disease. Brain 2006; 129: 3042-50.
11. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
12. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988; 24: 641-52.
13. Nelson HE. National Adult Reading Test. Test Manual. NferNelson, 1982.
14. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-8.
15. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, et al. Prevalence and classification of mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol 2003; 60: 1385-9.
16. Wenham PR, Price WH, Blanden G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-9.
17. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983; 17: 37-49.
18. De Jager CA, Budge MM, Clarke R. Utility of TICS-M for the assessment of cognitive function in older adults. Int J Geriatr Psychiatry 2003; 18: 318-24.
19. Foy CM, Nicholas H, Hollingworth P, Boothby H, Williams J, Brown RG, et al. Diagnosing Alzheimer's disease - non-clinicians and computerised algorithms together are as accurate as the best clinical practice. Int J Geriatr Psychiatry 2007; 22: 1154-63.
20. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986; 149: 698-709.
21. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811.
22. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing 1996; 25: 113-20.
23. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-14.
24. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiatry 1988; 23: 271-84.
25. Webster DD. Critical analysis of the disability in Parkinson's disease. Mod Treat 1968; 5: 257-82.
26. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabi S, Gelpi E, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 2007; 68: 288-91.
27. Yaffe K, Petersen RC, Lindquist K, Kramer J, Miller B. Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord 2006; 22: 312-9.
28. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 2008; 65: 1066-73.
29. Fillit H, Nash DT, Rundek T, Zuckerman A. Cardiovascular risk factors and dementia. Am J Geriatr Pharmacother 2008; 6: 100-18.
30. Barabash A, Marcos A, Ancín I, Vázquez-Alvarez B, de Ugarte C, Gil P, et al. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease. Neurobiol Aging 2009; 30: 1254-64.